1. Home
  2. FRPT vs AVDL Comparison

FRPT vs AVDL Comparison

Compare FRPT & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshpet Inc.

FRPT

Freshpet Inc.

HOLD

Current Price

$62.74

Market Cap

2.4B

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.33

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRPT
AVDL
Founded
2004
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
FRPT
AVDL
Price
$62.74
$21.33
Analyst Decision
Buy
Buy
Analyst Count
14
9
Target Price
$77.00
$18.38
AVG Volume (30 Days)
1.0M
2.8M
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
169.38
N/A
EPS
2.38
N/A
Revenue
$1,079,494,000.00
$248,517,000.00
Revenue This Year
$15.47
$65.47
Revenue Next Year
$9.95
$30.88
P/E Ratio
$25.87
N/A
Revenue Growth
16.34
79.88
52 Week Low
$46.76
$6.38
52 Week High
$164.07
$23.57

Technical Indicators

Market Signals
Indicator
FRPT
AVDL
Relative Strength Index (RSI) 71.63 59.15
Support Level $56.28 $21.32
Resistance Level $63.11 $21.62
Average True Range (ATR) 2.12 0.34
MACD 0.91 -0.31
Stochastic Oscillator 96.29 7.36

Price Performance

Historical Comparison
FRPT
AVDL

About FRPT Freshpet Inc.

Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: